NCT03737344View on ClinicalTrials.gov

BLOC-ICH: Interleukin-1 Receptor Antagonist in Intracerebral Haemorrhage

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 17, 2019

Primary Completion Date

February 19, 2021

Study Completion Date

April 30, 2021

Conditions
Intracerebral Haemorrhage
Interventions
DRUG

IL-1Ra Kineret®

Kineret® 100 mg in 0.67 ml Prefilled Syringe

OTHER

IL-1Ra Placebo

Placebo identical to Kineret® 100 mg in 0.67 ml Prefilled Syringe

Trial Locations (1)

M6 8HD

Salford Royal NHS Foundation Trust, Manchester

All Listed Sponsors
collaborator

Northern Care Alliance NHS Foundation Trust

OTHER

collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

collaborator

Manchester University NHS Foundation Trust

OTHER_GOV

lead

Adrian Parry-Jones

OTHER

NCT03737344 - BLOC-ICH: Interleukin-1 Receptor Antagonist in Intracerebral Haemorrhage | Biotech Hunter | Biotech Hunter